Interleukin-10 control of pre-miR155 maturation involves CELF2

PLoS One. 2020 Apr 23;15(4):e0231639. doi: 10.1371/journal.pone.0231639. eCollection 2020.

Abstract

The anti-inflammatory cytokine interleukin-10 (IL10) is essential for attenuating inflammatory responses, which includes reducing the expression of pro-inflammatory microRNA-155 (miR155) in lipopolysaccharide (LPS) activated macrophages. miR155 enhances the expression of pro-inflammatory cytokines such as TNFα and suppresses expression of anti-inflammatory molecules such as SHIP1 and SOCS1. We previously found that IL10 interfered with the maturation of pre-miR155 to miR155. To understand the mechanism by which IL10 interferes with pre-miR155 maturation we isolated proteins that associate with pre-miR155 in response to IL10 in macrophages. We identified CELF2, a member of the CUGBP, ELAV-Like Family (CELF) family of RNA binding proteins, as protein whose association with pre-miR155 increased in IL10 treated cells. CRISPR-Cas9 mediated knockdown of CELF2 impaired IL10's ability to inhibit both miR155 expression and TNFα expression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CELF Proteins / metabolism*
  • HEK293 Cells
  • Humans
  • Interleukin-10 / metabolism*
  • Lipopolysaccharides / pharmacology
  • Mice
  • MicroRNAs / genetics
  • MicroRNAs / metabolism*
  • Oligonucleotides / metabolism
  • Protein Binding
  • RAW 264.7 Cells
  • RNA Precursors / genetics
  • RNA Precursors / metabolism*
  • Reproducibility of Results
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • CELF Proteins
  • Celf2 protein, mouse
  • Lipopolysaccharides
  • MIRN155 microRNA, human
  • MicroRNAs
  • Oligonucleotides
  • RNA Precursors
  • Tumor Necrosis Factor-alpha
  • Interleukin-10

Grants and funding